← Eichor
Study identifier: NCT05704296 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Saphenous Vein as Y-composite Versus Aortocoronary Conduit for CABG

Condition: Coronary Artery Disease  ·  Sponsor: Ho Young Hwang

PhaseNA
Planned participants290
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second graft of choice among right internal thoracic artery, radial artery, right gastroepiploic artery, saphenous vein, and etc., as well as its configuration for CABG. In our institution, saphenous vein has been primarily used for the second graft and we have harvested it with 'No touch technique'. We have been demonstrated the excellent long-term patency of this 'No touch saphenous vein' in many studies. However, it is still unknown which configuration is the better strategy for the saphenous vein as a Y-composite graft based on the left internal thoracic artery versus an aortocoronary conduit. Thus, we aimed to evaluate morphologic change of saphenous vein graft by 1-year intravascular ultrasound (IVUS) study and angiographic patency results between Y-composite graft and aortocoronary conduit.

This description comes directly from the study's public registry record.

Talk to the study team

Ho Young Hwang, MD, PhD  ·  00-82-10-4004-3673  ·  scalpel@snu.ac.kr

Suk Ho Sohn, MD  ·  00-82-10-9114-3168  ·  shsohn@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05704296